CTS™ OpTmizer™ One SFM

Benefits:

• Provides enhanced T-cell expansion and expression of early memory phenotype makers compared to other chemically defined media
• Demonstrates flexibility across culture vessels. In both G-Rex™ plates and rocking bioreactors, it supports scale-up while maintaining desired T-cell phenotype.
• Expands both healthy and disease state donors
• Supports efficient viral and non-viral editing with downstream expansion
• Mitigates risk of contaminants and variability associated with animal-sourced materials
• Supports scale-up via larger catalog pack sizes

Features:

• Animal-origin-free (AOF) formulation
• Serum-free—designed without the need for serum or serum replacement
• No separate components—no need to mix basal medium with supplement to obtain complete medium
• Yields high density cultures
• Supports T-cell activation using CTS Dynabeads (both passive release CD3/CD28 (Cat. No.40203D) and detachable CD3/CD28 (Cat No. A56992))
• Available in 1 L bottle, 1 L bag, 5 L bag, and 10 L bag options

Increased efficiency and consistent performance:

CTS OpTmizer One SFM is an AOF formulation that supports high density cultures in static and dynamic vessels. It displays consistent performance for T-cell expansion, with better early memory phenotype at early stages.

Simplify your transition into clinical research:

The Gibco Cell Therapy Systems (CTS) portfolio offers a broad array of products for use in cell therapy applications, including media, reagents, growth factors, enzymes, cell selection/expansion reagents, and devices. CTS products deliver:

• Reduced burden in qualifying reagents
• Appropriate certificates of analysis and origin available
• Convenient access to our Drug Master File (DMF)